This topic contains a solution. Click here to go to the answer

Author Question: Sry protein triggers the development of the medullas of the primordial gonads into A) testes. ... (Read 129 times)

javeds

  • Hero Member
  • *****
  • Posts: 570
Sry protein triggers the development of the medullas of the primordial gonads into
 
  A) testes.
  B) a Mllerian system.
  C) the penis.
  D) ovaries.
  E) a Wolffian system.

Question 2

In the absence of Sry protein, the
 
  A) cortex of a primordial gonad develops into an ovary.
  B) medulla of a primordial gonad develops into a testis.
  C) Mllerian system develops into male ducts.
  D) cortex of a primordial gonad develops into a testis.
  E) medulla of a primordial gonad develops into an ovary.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

alexanderhamilton

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

Answer: A

Answer to Question 2

Answer: A




javeds

  • Member
  • Posts: 570
Reply 2 on: Jun 22, 2018
Great answer, keep it coming :)


upturnedfurball

  • Member
  • Posts: 334
Reply 3 on: Yesterday
Excellent

 

Did you know?

The Babylonians wrote numbers in a system that used 60 as the base value rather than the number 10. They did not have a symbol for "zero."

Did you know?

The modern decimal position system was the invention of the Hindus (around 800 AD), involving the placing of numerals to indicate their value (units, tens, hundreds, and so on).

Did you know?

Cancer has been around as long as humankind, but only in the second half of the twentieth century did the number of cancer cases explode.

Did you know?

Vital signs (blood pressure, temperature, pulse rate, respiration rate) should be taken before any drug administration. Patients should be informed not to use tobacco or caffeine at least 30 minutes before their appointment.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library